Scynexis (SCYX) EPS (Basic) Growth (1y) (2014 - 2026)
Scynexis (SCYX) EPS (Basic) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | 45.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.84% |
| Mar 31, 2026 | -195.65% |
| Dec 31, 2025 | 365.71% |
| Sep 30, 2025 | -198.10% |
| Jun 30, 2025 | 53.56% |
| Mar 31, 2025 | -1,380.11% |
| Dec 31, 2024 | 79.21% |
| Sep 30, 2024 | -57.43% |
| Jun 30, 2024 | -111.66% |
| Mar 31, 2024 | 101.20% |
| Dec 31, 2023 | 2.88% |
| Sep 30, 2023 | 94.11% |
| Jun 30, 2023 | 928.97% |
| Mar 31, 2023 | -317.08% |
| Dec 31, 2022 | 58.76% |
| Sep 30, 2022 | -2,639.84% |
| Jun 30, 2022 | -583.75% |
| Mar 31, 2022 | 6.15% |
| Dec 31, 2021 | 64.57% |
| Sep 30, 2021 | -126.58% |